title: Ouabain- and marinobufagenin-induced proliferation of human umbilical vein smooth muscle cells and a rat vascular smooth muscle cell line, A7r5.
abstract: BACKGROUND
  We studied the growth-promoting effects of 2 sodium pump-selective cardiotonic steroids, ouabain and marinobufagenin, on cultured cells from vascular smooth muscle (VSMCs) from human umbilical vein and a rat VSMC line, A7r5.
  
  
  RESULTS
  Both ouabain and marinobufagenin activated proliferation of these cells in a concentration-dependent manner, reflecting the cardiotonic steroid sensitivity of the specific alpha1 subunit contained within each cell source. The observed effective concentration ranges of both compounds was below that necessary to induce cytoplasmic ion alterations by sodium pump inhibition.
  
  
  CONCLUSIONS
  These data indicate that the ouabain-activated proliferative effect previously observed in canine VSMCs occurs in other VSMC sources. This growth effect seems to be initiated by drug interaction with the sodium pump, reflected by the affinity of the steroid for the pump, and is independent of altered transmembrane ionic gradients.
authors.affiliation: Department of Medicine, Section of Cardiovascular Science, Baylor College of Medicine, Houston, Tex 77030, USA.
authors.forename: Joel
authors.initials: J
authors.lastname: Abramowitz
authors.forename: Cuiping
authors.initials: C
authors.lastname: Dai
authors.forename: Karen K
authors.initials: KK
authors.lastname: Hirschi
authors.forename: Renata I
authors.initials: RI
authors.lastname: Dmitrieva
authors.forename: Peter A
authors.initials: PA
authors.lastname: Doris
authors.forename: Lijun
authors.initials: L
authors.lastname: Liu
authors.forename: Julius C
authors.initials: JC
authors.lastname: Allen
mesh_terms: D000818:Animals; D002018:Bufanolides / Q000494:pharmacology*; D002316:Cardiotonic Agents / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002478:Cells, Cultured; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D006801:Humans; D008024:Ligands; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000187:drug effects* / Q000201:enzymology; D010042:Ouabain / Q000494:pharmacology*; D051381:Rats; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D014471:Umbilical Veins / Q000166:cytology
chemical_list: D002018:Bufanolides; D002316:Cardiotonic Agents; D004791:Enzyme Inhibitors; D008024:Ligands; C093896:marinobufagenin; D010042:Ouabain; D000254:Sodium-Potassium-Exchanging ATPase